FOCUS ON
Lithium: bipolar maintenance, ↓ suicide; mechanism — ↓ inositol recycling (IP₃).
Narrow index, renally cleared like Na⁺ → levels ↑ with
thiazides, ACEi/ARBs, NSAIDs, dehydration. Adverse: tremor,
nephrogenic DI,
hypothyroidism, hypercalcemia, acne, weight gain, leukocytosis,
Ebstein anomaly. Toxicity: coarse tremor, ataxia, confusion, seizures → hemodialysis.
Valproate, carbamazepine, lamotrigine (bipolar depression), atypical antipsychotics also stabilize mood.
Benzodiazepines: ↑
frequency of GABA-A Cl⁻ opening; anxiety, panic (short term), alcohol withdrawal (chlordiazepoxide, diazepam; lorazepam/oxazepam/temazepam in liver disease), seizures, sedation. Adverse: sedation, falls, dependence, respiratory depression with alcohol/opioids →
flumazenil (can cause seizures).
Barbiturates: ↑
duration of opening; CYP inducers; no ceiling.
Z-drugs (zolpidem, eszopiclone): BZ1; complex sleep behaviors.
Buspirone: 5-HT1A partial agonist; GAD; no sedation or dependence; weeks to work.
Hypnotics: ramelteon (melatonin), suvorexant (orexin), doxepin low dose, trazodone.